Literature DB >> 28591119

Manufacture of CAR-T cells in the body.

Johanna Olweus1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28591119     DOI： 10.1038/nbt.3898

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  9 in total

Review 1.  Targeting cancer-specific mutations by T cell receptor gene therapy.

Authors:  Thomas Blankenstein; Matthias Leisegang; Wolfgang Uckert; Hans Schreiber
Journal:  Curr Opin Immunol       Date:  2015-02-27       Impact factor: 7.486

2.  The future of cancer treatment: immunomodulation, CARs and combination immunotherapy.

Authors:  Danny N Khalil; Eric L Smith; Renier J Brentjens; Jedd D Wolchok
Journal:  Nat Rev Clin Oncol       Date:  2016-04-26       Impact factor: 66.675

3.  Endogenous Transposase Source in Human Cells Mobilizes piggyBac Transposons.

Authors:  Zoltán Ivics
Journal:  Mol Ther       Date:  2016-05       Impact factor: 11.454

4.  Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells.

Authors:  Partow Kebriaei; Harjeet Singh; M Helen Huls; Matthew J Figliola; Roland Bassett; Simon Olivares; Bipulendu Jena; Margaret J Dawson; Pappanaicken R Kumaresan; Shihuang Su; Sourindra Maiti; Jianliang Dai; Branden Moriarity; Marie-Andrée Forget; Vladimir Senyukov; Aaron Orozco; Tingting Liu; Jessica McCarty; Rineka N Jackson; Judy S Moyes; Gabriela Rondon; Muzaffar Qazilbash; Stefan Ciurea; Amin Alousi; Yago Nieto; Katy Rezvani; David Marin; Uday Popat; Chitra Hosing; Elizabeth J Shpall; Hagop Kantarjian; Michael Keating; William Wierda; Kim Anh Do; David A Largaespada; Dean A Lee; Perry B Hackett; Richard E Champlin; Laurence J N Cooper
Journal:  J Clin Invest       Date:  2016-08-02       Impact factor: 14.808

Review 5.  Adoptive cell transfer as personalized immunotherapy for human cancer.

Authors:  Steven A Rosenberg; Nicholas P Restifo
Journal:  Science       Date:  2015-04-03       Impact factor: 47.728

6.  In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers.

Authors:  Tyrel T Smith; Sirkka B Stephan; Howell F Moffett; Laura E McKnight; Weihang Ji; Diana Reiman; Emmy Bonagofski; Martin E Wohlfahrt; Smitha P S Pillai; Matthias T Stephan
Journal:  Nat Nanotechnol       Date:  2017-04-17       Impact factor: 39.213

Review 7.  Therapeutic genome editing: prospects and challenges.

Authors:  David Benjamin Turitz Cox; Randall Jeffrey Platt; Feng Zhang
Journal:  Nat Med       Date:  2015-02       Impact factor: 53.440

8.  Prospects for gene-engineered T cell immunotherapy for solid cancers.

Authors:  Christopher A Klebanoff; Steven A Rosenberg; Nicholas P Restifo
Journal:  Nat Med       Date:  2016-01       Impact factor: 53.440

Review 9.  Neoantigens in cancer immunotherapy.

Authors:  Ton N Schumacher; Robert D Schreiber
Journal:  Science       Date:  2015-04-03       Impact factor: 47.728
  9 in total
  5 in total

Review 1.  Advances in CAR-T Cell Genetic Engineering Strategies to Overcome Hurdles in Solid Tumors Treatment.

Authors:  Alain E Andrea; Andrada Chiron; Sarah Mallah; Stéphanie Bessoles; Guillaume Sarrabayrouse; Salima Hacein-Bey-Abina
Journal:  Front Immunol       Date:  2022-02-08       Impact factor: 7.561

Review 2.  The Potential of Donor T-Cell Repertoires in Neoantigen-Targeted Cancer Immunotherapy.

Authors:  Terhi Karpanen; Johanna Olweus
Journal:  Front Immunol       Date:  2017-12-11       Impact factor: 7.561

Review 3.  Immuno-Oncology: Emerging Targets and Combination Therapies.

Authors:  Henry T Marshall; Mustafa B A Djamgoz
Journal:  Front Oncol       Date:  2018-08-23       Impact factor: 6.244

4.  Primary allogeneic mitochondrial mix (PAMM) transfer/transplant by MitoCeption to address damage in PBMCs caused by ultraviolet radiation.

Authors:  Francisco Cabrera; Mayra Ortega; Francesca Velarde; Eliseo Parra; Stephany Gallardo; Diego Barba; Lina Soto; Gabriela Peña; Luis Alberto Pedroza; Christian Jorgensen; Maroun Khoury; Andrés Caicedo
Journal:  BMC Biotechnol       Date:  2019-06-28       Impact factor: 2.563

Review 5.  Targeting Natural Killer Cells for Tumor Immunotherapy.

Authors:  Cai Zhang; Yuan Hu; Chongdeng Shi
Journal:  Front Immunol       Date:  2020-02-19       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.